Erectile dysfunction may signal early atherosclerosis

October 11, 2005

(BETHESDA, MD) - Erectile dysfunction may be a sign that coronary artery disease is developing, even in men without typical risk factors, according to a new study in the Oct. 18, 2005, issue of the Journal of the American College of Cardiology.

"We think that erectile dysfunction represents the 'tip of the iceberg' of a systemic vascular disorder; thus potentially preceding severe cardiovascular events. Erectile dysfunction should be part of a cardiovascular risk assessment. These patients should be considered at high risk for coronary artery disease and should have high priority for aggressive treatment," said Emilio Chiurlia, Ph.D. from the University of Modena and Reggio Emilia in Modena, Italy.

The researchers studied 70 men with erectile dysfunction and 73 control subjects who were of similar age and race (all Caucasian), and had similar coronary risk factor scores according to estimates published by the National Cholesterol Education Panel III. None of the men had symptoms of coronary atherosclerosis.

The men with erectile dysfunction had higher levels of C-reactive protein (an emerging coronary risk factor), they were more likely to have abnormal blood vessel responses to changes in blood flow (as measured by flow mediated dilation), and more of them had coronary artery calcifications detected on coronary CT scans.

"When a man is diagnosed with erectile dysfunction, clinicians should be aware that erectile dysfunction would represent an early clinical manifestation of a diffuse subclinical vascular disease and coronary artery disease is the most important problem that needs to be investigated. The smaller penile arteries suffer obstruction from plaque burden earlier than the larger coronary arteries hence erectile dysfunction may be symptomatic before a coronary event," Dr. Chiurlia said.

Dr. Chiurlia noted that this study involved only a small number of men and did not follow them over time to see which ones actually developed heart disease.

"We need prospective studies addressing the precise role of erectile dysfunction as a marker of cardiovascular disease," he said.

While awaiting the results of such future studies, he said erectile dysfunction should raise suspicions about early atherosclerosis, even in men who would not otherwise be considered at high risk.

"In our opinion, erectile dysfunction should be considered, like diabetes, a 'cardiovascular equivalent,'" Dr. Chiurlia said.

Renke Maas, M.D., from the University-Hospital Hamburg-Eppendorf in Hamburg, Germany, who was not connected with this research, agreed with the main conclusion of the study.

"The present study by Chiurlia et al. lends strong support to the notion that erectile dysfunction may be an early warning sign of clinically-silent coronary artery disease. Despite limitations set by sample size and the cross-sectional study design with a long list of exclusion criteria, it is a strength of the present work that it assesses major aspects connecting erectile dysfunction and more generalized vascular disease in one study," Dr. Maas said.

Paul Schoenhagen, M.D., from the Cleveland Clinic Foundation in Cleveland, Ohio, who also was not connected with the research, said it provides evidence of related problems in two different regions of the arterial tree.

"These results demonstrate the systemic nature of atherosclerosis and the relationship to an inflammatory process of the vessel wall. This understanding of atherosclerosis increasingly allows early interventions aimed at the prevention of disease complications," Dr. Schoenhagen said.
-end-
Disclosure Box

Sources quoted in this news release do not report any potential conflicts of interest regarding this topic.

American College of Cardiology

Related Atherosclerosis Articles from Brightsurf:

How hormone therapy slows progression of atherosclerosis
As one of the most common treatments for effectively managing menopause symptoms, hormone therapy (HT) is also known to provide multiple health benefits, including slowing the progression of atherosclerosis.

T cells can shift from helping to harming in atherosclerosis
At La Jolla Institute for Immunology (LJI) researchers are dedicated to finding a way to stop plaques from forming in the first place.

New nanoparticle drug combination for atherosclerosis
Physicochemical cargo-switching nanoparticles (CSNP) designed by KAIST can help significantly reduce cholesterol and macrophage foam cells in arteries, which are the two main triggers for atherosclerotic plaque and inflammation.

Atherosclerosis -- How a microRNA protects vascular integrity
Ludwig-Maximilian-Universitaet (LMU) in Munich researchers have discovered a hitherto unknown molecular function of a specific microRNA that preserves integrity of the endothelium and reduces the risk of atherosclerosis.

Atherosclerosis progresses rapidly in healthy people from the age of 40
A CNIC study published in JACC demonstrates that atheroma plaques extend rapidly in the arteries of asymptomatic individuals aged between 40 and 50 years participating in the PESA-CNIC-Santander study.

Scaling up a nanoimmunotherapy for atherosclerosis through preclinical testing
By integrating translational imaging techniques with improvements to production methods, Tina Binderup and colleagues have scaled up a promising nanoimmunotherapy for atherosclerosis in mice, rabbits and pigs -- surmounting a major obstacle in nanomedicine.

Bladder drug linked to atherosclerosis in mice
A drug used in the treatment of overactive bladder can accelerate atheroclerosis in mice, researchers at Karolinska Institutet in Sweden report in a study published in the Proceedings of the National Academy of Sciences (PNAS).

A new therapeutic target for blocking early atherosclerosis in progeria
Researchers at the Centro Nacional de Investigaciones Cardiovasculares and the Universidad de Oviedo have discovered a new molecular mechanism involved in the premature development of atherosclerosis in mice with Hutchinson-Gilford progeria syndrome.

Protective mechanism against atherosclerosis discovered
Immune cells promoting inflammation play a crucial role in the development of atherosclerosis.

Atherosclerosis: Stopped on time
For the first time, LMU researchers are pointing out the influence of the internal clock on atherosclerosis.

Read More: Atherosclerosis News and Atherosclerosis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.